Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.
Chronic hepatic inflammation from multiple etiologies leads to a fibrogenic response that can progress to cirrhosis and liver failure. Transplantation of human amniotic epithelial cells (hAEC) from term delivered placenta has been shown to decrease mild to moderate hepatic fibrosis in a murine model...
Guardado en:
Autores principales: | Ursula Manuelpillai, Dinushka Lourensz, Vijesh Vaghjiani, Jorge Tchongue, Derek Lacey, Jing-Yang Tee, Padma Murthi, James Chan, Alexander Hodge, William Sievert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36375001dadc44e0b23cd03686a58377 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications.
por: Gita Pratama, et al.
Publicado: (2011) -
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
por: Yu Han Liu, et al.
Publicado: (2012) -
Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study.
por: Yuben Moodley, et al.
Publicado: (2013) -
Amniotic Membrane Transplantation for Persistent Epithelial Defects and Ulceration due to Pseudomonas Keratitis in a Rabbit Model
por: Mohammad Mehdi Soltan Dallal, et al.
Publicado: (2021) -
Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective
por: Walkden A
Publicado: (2020)